In another study the expression of BAALC was higher in CD34+ patients with AML.32 However, some studies found no significant difference in CD34+ between high and low expression groups of BAALC.29 There was also no significant difference between CD34+ and CD34- in terms of WT-1 expression in Anderson et al study4 that was similar to our results. The gene discussed is BAALC; the disease is acute myeloid leukemia.